Synergy CHC Corp. will release its 2025 financial results on April 1, 2026, with a conference call following.
Quiver AI Summary
Synergy CHC Corp. announced that it will release its fourth quarter and full year financial results for the period ending December 31, 2025, on April 1, 2026, before the market opens. The company's CEO, Jack Ross, and CFO, Jaime Fickett, will host a conference call at 9:00 a.m. ET to discuss the results, which will be accessible via a live webcast on Synergy's website. Participants are encouraged to register in advance and join the call 15 minutes early. Synergy CHC Corp. develops consumer health products, including the brain health supplement FOCUSfactor® and the lifestyle brand Flat Tummy®, aimed at women’s wellness.
Potential Positives
- Synergy CHC Corp. is set to release its fourth quarter and full year financial results, signaling transparency and commitment to shareholder communication.
- The scheduled conference call with CEO Jack Ross and CFO Jaime Fickett demonstrates leadership engagement, allowing direct interaction between executives and investors.
- FOCUSfactor® shows strong market performance, with established distribution through major retailers and expansion into new markets, indicating business growth potential.
- Flat Tummy® complements the company's portfolio in the wellness sector, targeting a specific demographic and enhancing brand diversity.
Potential Negatives
- The announcement of a revised date for financial results could signal previous delays or issues in financial reporting, which may raise concerns among investors about the company's financial health and transparency.
- Releasing fourth quarter and full year results on April 1 (April Fools' Day) may unintentionally undermine investor confidence, as it could be perceived as a lack of seriousness regarding financial disclosures.
- While no specific financial metrics are provided in the release, the absence of critical information about performance could heighten uncertainty among stakeholders about the company's growth and stability.
FAQ
When will Synergy CHC Corp. release its financial results?
Synergy CHC Corp. will release its financial results on April 1, 2026, before market open.
Who will participate in the conference call?
The conference call will feature CEO Jack Ross and CFO Jaime Fickett.
How can I access the conference call?
Participants can access the call by phone or through a live webcast on the Investor Relations section of Synergy's website.
What are the main brands of Synergy CHC Corp.?
Synergy's flagship brands include FOCUSfactor® and Flat Tummy®, focusing on brain health and women's wellness.
Where can I find the replay of the webcast?
A replay of the conference call webcast will be available on Synergy's website for a limited time.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SNYR Revenue
$SNYR had revenues of $8M in Q3 2025. This is an increase of 12.4% from the same period in the prior year.
You can track SNYR financials on Quiver Quantitative's SNYR stock page.
$SNYR Hedge Fund Activity
We have seen 9 institutional investors add shares of $SNYR stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SANDERS MORRIS HARRIS LLC removed 391,702 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $728,565
- VANGUARD GROUP INC added 29,100 shares (+44.1%) to their portfolio in Q4 2025, for an estimated $54,126
- XTX TOPCO LTD removed 20,130 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $49,117
- WARBERG ASSET MANAGEMENT LLC removed 19,844 shares (-59.2%) from their portfolio in Q4 2025, for an estimated $36,909
- DRW SECURITIES, LLC added 19,487 shares (+inf%) to their portfolio in Q4 2025, for an estimated $36,245
- VIRTU FINANCIAL LLC removed 15,698 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $29,198
- CITADEL ADVISORS LLC added 13,809 shares (+inf%) to their portfolio in Q4 2025, for an estimated $25,684
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SNYR Analyst Ratings
Wall Street analysts have issued reports on $SNYR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Roth Capital issued a "Buy" rating on 11/14/2025
To track analyst ratings and price targets for $SNYR, check out Quiver Quantitative's $SNYR forecast page.
$SNYR Price Targets
Multiple analysts have issued price targets for $SNYR recently. We have seen 2 analysts offer price targets for $SNYR in the last 6 months, with a median target of $6.0.
Here are some recent targets:
- Edward Woo from Ascendiant Capital set a target price of $5.0 on 02/02/2026
- Sean McGowan from Roth Capital set a target price of $7.0 on 11/14/2025
Full Release
WESTBROOK, Maine, March 30, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced an updated date for the release of its fourth quarter and full year financial results ended December 31, 2025. The Company will now report its financial results on Wednesday, April 1, 2026, before the open of market trading.
In conjunction with reporting fourth quarter and full year 2025 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Company’s Chief Executive Officer, Jack Ross, and the Company’s Chief Financial Officer, Jaime Fickett. A live webcast of the call will be available on the Investor Relations section of Synergy’s website. To access the call by phone, please register here and you will be provided with dial-in details. To avoid delays, we encourage participants to dial into the conference call 15 minutes ahead of the scheduled start time. A replay of the webcast will also be available for a limited time on the Company’s website.
About Synergy CHC Corp.
Synergy CHC Corp. develops and markets consumer health and wellness products, led by its flagship brands FOCUSfactor ® and Flat Tummy ® . FOCUSfactor ® , a clinically studied brain health supplement and functional beverage line with a 25-year legacy, enjoys established distribution in the U.S., Canada, Mexico and the U.K. through major retailers including Costco, Walmart, Amazon, BJ's, and Walgreens, among others. The brand continues to accelerate growth, penetrating new markets both domestically and internationally, with recent retail wins across mass, grocery, pharmacy, convenience, and wholesale channels poised to drive meaningful gains. Flat Tummy ® complements Synergy's portfolio as a lifestyle brand focused on women's wellness and weight management.
Investor Relations
Gateway Group
Cody Slach, Greg Robles
949.574.3860
[email protected]
